InvestorsHub Logo
Followers 3
Posts 321
Boards Moderated 0
Alias Born 12/21/2022

Re: None

Thursday, 01/30/2025 9:13:17 AM

Thursday, January 30, 2025 9:13:17 AM

Post# of 242
Data from same day dosing trial will be presented at ACCC 51st Annual Meeting & Cancer Center Business Summit on March 5, 2025. Title: Eflapegrastim, a Long-Acting GCSF, Administered the Same Day as Chemotherapy in Patients with Early-Stage Breast Cancer: Results from a Multicenter, Open-Label, Study.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ASRT News